Introduction
The tandemly linked p15
INK4b and p16 INK4a genes encode related cyclin dependent kinase inhibitors which are upstream regulators in the retinoblastoma (Rb) pathway that controls the G1 to S cell cycle checkpoint.
1 p19 ARF operates upstream of the p53 pathway as it binds MDM2 which is a negative regulator of p53. 2, 3 The p16 INK4a and p19 ARF transcripts are derived from separate promoters and first exons (E1␣ and E1␤, respectively), and although they share exons 2 and 3, exons 1␣ and 1␤ are spliced to exon 2 in different reading frames so the two gene products share no amino acid homology. 4, 5 All three promoters in mouse and man are CpG-rich characteristic of house-keeping genes. 6, 7 The regulatory roles of the p15 INK4b , p16 INK4a and p19 ARF gene products in the cell cycle and apoptotic pathways make them intrinsic tumour suppressor genes. 2, 8, 9 The INK/ARF locus maps to human chromosome 9p21. 4, [10] [11] [12] Loss of function due to inactivation of one or more of these genes by homozygous deletions, or allelic loss and mutation or de novo promoter hypermethylation of the remaining allele has been reported in many malignancies including breast, melanoma, leukaemia, bladder, lung and pituitary. [13] [14] [15] [16] [17] In the mouse, molecular genetic analyses of radiationinduced thymic lymphomas (TL) revealed a 45-66% chromosome 4 LOH incidence, and identified three commonly deleted regions (thymic lymphoma suppressor regions 1-3, TLSR1-3) within a 30 cM interval. [18] [19] [20] frequently detected in radiation-induced TLs (42% and 15% respectively). 1 However, chromosome 4 LOH in mouse radiation-induced TLs is mouse strain dependent as TLs which arose in a (BALB/c × MSM) genetic background have a negligible LOH incidence 21 compared to the LOH incidence in TLs which arose in (C57BL/6 × RF/J)F1 or (C57BL/6 × CBA/H) genetic backgrounds. 18, 19 We recently detected a 45% incidence of chromosome 4 LOH in 3 Gy X-ray-induced mouse acute myeloid leukaemias (AMLs) as well as a 66% incidence in TLs. 19 Whilst mouse TLs are generally induced as a consequence of a fractionated dose of X-rays, 18, 21 in our study, (CBA/H × C57BL/6)F1 backcross and intercross mice were exposed to a single acute X-ray dose. As CBA/H mice are susceptible to radiationinduced AML, and C57BL/6 mice are susceptible to radiationinduced TL, 22, 23 AMLs and TLs were generated in a similar genetic background as a consequence of the same initiating event.
We tested the hypothesis that inactivation of the p15
INK4a and/or p19 ARF genes by homozygous deletion and/or by allelic loss and promoter hypermethylation is associated with both myeloid (AML) and lymphoid (TL) mouse radiationleukaemogenesis whilst minimising confounding genetic factor(s). Although a significant incidence (21%) of p15 INK4b gene promoter hypermethylation was detected in the TLs consistent with other studies, 1, 18 p15 INK4b promoter hypermethylation was infrequently detected in the AMLs (3.1%), and p16
INK4a and p19 ARF gene promoter methylation infrequently (Ͻ3%) detected in either leukaemia. Thus, inactivation of the p15
INK4b multi-tumour suppressor gene by allelic loss and promoter hypermethylation is a feature of radiation-induced mouse lymphoid but not myeloid radiation-induced leukaemias.
Materials and methods

Induction of tumours in mice
Eight-week-old CBA/H, (CBA/H × C57BL/6)F1 or F1 backcross (F1 × CBA/H or F1 × C57BL/6) and F1 × F1 intercross mice were exposed to a single acute dose of 3 Gy X-rays. Leukaemias were diagnosed by microscopic examination of blood, bone marrow, spleen and thymus. The AML incidence in the inbred CBA/H mice was 20%, consistent with previous studies. 22 The AML and TL incidence in F1 × C57BL/6 (AML: 8%; TL:10%) and F1 × F1 (AML: 8%; TL: 7%) mice was similar. Only F1 × CBA/H mice had a significant difference in the incidence of myeloid (8%) and lymphoid (2%) leukaemias.
Animal studies were carried out under guidance issued by the MRC in 'Responsibility in the Use of Animals for Medical Research' (July 1993) and Home Office Project Licence PPL/30/689 and 30/1272. 6 and the p19 ARF exon 1␤-specific probe was as described. 24 
Southern blot analyses
Control spleen or leukaemic thymus/spleen genomic DNA was digested with ෂ4 units/g DNA of restriction enzyme (EcoRI, MspI or HpaII; GIBCO/BRL, Paisley, UK) at 37°C over a period of ෂ24 h under the conditions recommended by the supplier. DNA digests were ethanol precipitated, and in the case of double digests (EcoRI/SstII and EcoRI/XhoI), digested for a further 24 h at 37°C with ෂ7 units/g DNA of SstII or XhoI, followed by ethanol precipitation. DNA (10-15 g) was resolved by 0.9%-2.0% (w/v) agarose gel electrophoresis in the presence of ethidium bromide (1 g/ml), transferred to Genescreen membranes (Dupont, Boston, MA, USA) and hybridized to ␣-32 P-dATP labelled probes (Random prime kit, GIBCO/BRL) essentially as described. 25 Either sufficient genomic DNA was digested to run two parallel blots to control for complete digestion, and/or membranes were stripped and reprobed as appropriate.
Results and discussion
To optimise the detection of p15 INK4b , p16 INK4a and/or p19 ARF gene promoter/exon 1 region methylation in the AMLs and TLs, we analysed leukaemic DNA at 2-3 methyl-sensitive restriction sites per gene, using exon 1-specific probes. Partial methylation of XhoI (Figure 1a ; lanes 7, 9 and 10), HpaII (Figure 1b ; lanes 1 and 2) and/or SstII (data not shown) methylsensitive restriction sites within the mouse p15
INK4b and p16
INK4a gene promoter/exon 1 regions has been described. 1, 24, 26 Restriction map analyses of control spleen genomic DNA also identified XhoI and SstII restriction sites within 450-700 bp of the p19 ARF exon 1␤ (data not shown) and a HpaII site identified within exon 1␤.
HpaII digests were compared to digests with the methylresistant MspI isoschizomer (Figure 1b) , and methylation at HpaII site(s) resulted in either small discrete increases in molecular weight (ෂ400 bp, Figure 1b, lanes 1 and 2) , or very high molecular weight band/smears (data not shown). The small (ෂ50 bp) difference in the electrophoretic mobilities of the complete MspI and HpaII digests (Figure 1b) is an artefact of electrophoresis. This ෂ50 bp difference was eliminated if the HpaII digested DNAs were also digested with EcoRI which cleaves outside the MspI/HpaII sites. 6 We therefore attribute this to the extreme differences in the average molecular weights of the MspI and HpaII genomic DNA digests (Ref. 27 and data not shown).
To confirm that partial digestion at specific restriction sites represented methylation as opposed to incomplete digestion, the same genomic DNA digests were analysed using two to three probes: XhoI (p15 INK4b 1-2, 3-4 , and 5-6). Complete HpaII digestion was confirmed by reprobing with the p19 ARF probe.
ation status of these SstII sites was not confirmed, the data are not included in Table 1 . The methylation status of the three promoters at individual methyl-sensitive restriction sites in the AMLs and TLs are summarised in Table 1 . No difference was observed in AMLs which arose in F1 × CBA/H (20 AMLs), F1 × C57BL/6 (12 AMLs), F1 × F1 (14 AMLs) or inbred CBA/H (17 AMLs) mice. Similarly, there was no significant difference observed in TLs which arose in F1 × CBA/H (6 TLs), F1 × C57BL/6 (16 TLs) or F1 × F1 (15 TLs) mice. Only one example of homozygous deletion at this gene cluster, involving p16
INK4a exon 1␤ (an F1 × C57BL/6 TL, data not shown), was detected in our study of ෂ100 leukaemias (AMLs and TLs).
The data for the methylation status of the p15 INK4b and p16
INK4a genes in the TLs (21% and 0%, respectively; Table  1 ) which arose in the (CBA/H × C57BL/6) genetic background is similar to that reported for radiation-induced (C57BL/6J × RF/J)F1 TLs. 6 Although our data is somewhat lower than that reported, 6 it should be noted that the incidence of p15 = 25%), 6 and that the X-irradiation protocols were different; a single 3 Gy acute exposure (this report) and 4 × 1.75 Gy fractionated exposure at weekly intervals. Results include AMLs and TLs which arose in inbred CBA/H and F1 (CBA/H × C57BL/6) intercross and backcross mice. Leukaemias which showed methylation at more than one promoter restriction site are only counted once in the final total (Xhol + SstII + HpaII). ND, not determined.
Together with our data on the methylation status of the p19 ARF gene promoter, the data (Table 1 , and Ref. 6 ) suggest that disruption of the regulation of the G1/S cell cycle checkpoint through the inactivation of the p15
INK4b (and to a lesser degree the p16 INK4a ) gene, plays a greater role in mouse lymphoid radiation leukaemogenesis than the disruption of the apoptotic pathway. We have not excluded the possibility of p19 ARF gene mutations, however gel electrophoresis of undigested TL DNA revealed DNA laddering in 50% of samples, (data not shown), suggesting that at least one apoptotic pathway is functional.
As summarised in Table 1 , the incidence of p15
